ATEX
Anterix Inc.
ATEX's outlook is improving, though it still trails on the overall score.
META
Meta Platforms, Inc.
META has the edge over ATEX overall, supported by lower modeled downside and stronger modeled upside.
ATEX Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
ATEX's revenue, profitability, cash flow and balance sheet are all currently healthy.
META Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
META's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
ATEX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.4x | $3.19 | -96% |
| Fair | 20x | $7.73 | -91% |
| Expensive | 44x | $16.81 | -80% |
| Current | 218x | $82.69 | — |
Historical ranges are pointers, not guarantees.
ATEX's PE is in its expensive range at 218x.
META PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $624 | — |
| Cheap | 21x | $613 | -1.7% |
| Current | 21x | $624 | — |
| Fair | 27x | $803 | +29% |
| Expensive | 32x | $934 | +50% |
Historical ranges are pointers, not guarantees.
META has the edge over ATEX in the historical PE scenario, which offers more potential upside but is not a forecast.
ATEX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect ATEX's losses to shrink, with revenue growing.
META Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for META, but weaker profitability. However, they disagree widely on these estimates.
ATEX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.38 | -93% |
| Q2 2026 | $3.49 | +121% |
| Q1 2026 | $4.83 | +$5.44 |
| Q4 2025 | $4.37 | +$6.00 |
| Q3 2025 | $5.13 | +$7.15 |
| Q2 2025 | $1.58 | +$2.80 |
| Q1 2025 | -$0.61 | -$0.12 |
| Q4 2024 | -$1.63 | -294% |
ATEX's earnings per share have fallen from their peak: $0.38 over the past year, against $5.13 in late 2025.
META Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $32.16 | +9.7% |
| Q3 2026 | $29.32 | +30% |
| Q2 2026 | $26.54 | -3.7% |
| Q1 2026 | $27.50 | +7.5% |
| Q4 2025 | $23.49 | -1.6% |
| Q3 2025 | $22.58 | +6.5% |
| Q2 2025 | $27.56 | +41% |
| Q1 2025 | $25.58 | +47% |
| Q4 2024 | $23.86 | +60% |
META has the edge over ATEX on earnings, with more consistent year-over-year improvement.
ATEX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2M | +26% |
| Q2 2026 | $2M | +38% |
| Q1 2026 | $2M | +41% |
| Q4 2025 | $1.6M | +0.4% |
| Q3 2025 | $1.6M | +0.1% |
| Q2 2025 | $1.4M | -7% |
| Q1 2025 | $1.4M | +10% |
| Q4 2024 | $1.6M | +23% |
ATEX's revenue has grown year over year for five quarters in a row: $2M last quarter, up 26% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -292% | -4201 points |
| Q2 2026 | -13% | -1598 points |
| Q1 2026 | 1013% | +337 points |
| Q4 2025 | -576% | -1025 points |
| Q3 2025 | 3909% | +4756 points |
| Q2 2025 | 1585% | +2570 points |
| Q1 2025 | 676% | +1511 points |
| Q4 2024 | 449% | +373 points |
ATEX's operating margin was −292% last quarter, down 4201 points from the same quarter a year ago.
META Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.6B | +26% |
| Q2 2026 | $60.8B | +28% |
| Q1 2026 | $56.3B | +33% |
| Q4 2025 | $59.9B | +24% |
| Q3 2025 | $51.2B | +26% |
| Q2 2025 | $47.5B | +22% |
| Q1 2025 | $42.3B | +16% |
| Q4 2024 | $48.4B | +21% |
META has the edge over ATEX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -20 points |
| Q2 2026 | 31% | -12 points |
| Q1 2026 | 41% | -0.9 points |
| Q4 2025 | 41% | -7 points |
| Q3 2025 | 40% | -2.7 points |
| Q2 2025 | 43% | +5 points |
| Q1 2025 | 41% | +3.6 points |
| Q4 2024 | 48% | +7.4 points |
META has the edge over ATEX on profitability, with a higher operating margin.
ATEX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $2M | +$5.1M |
| Q1 2026 | $15.5M | +$32.1M |
| Q4 2025 | -$8.3M | -$582K |
| Q2 2025 | -$3.1M | -$779K |
| Q1 2025 | -$16.6M | -372% |
| Q4 2024 | -$7.7M | -123% |
| Q3 2024 | -$2.7M | -126% |
| Q2 2024 | -$2.4M | +$5.9M |
ATEX has the stronger cash trend. Its trailing FCF is up 204% versus its history, compared with META at down 24%.
META Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -110% |
| Q2 2026 | $1.7B | -81% |
| Q1 2026 | $13.2B | +19% |
| Q4 2025 | $14.8B | +9.3% |
| Q3 2025 | $11.2B | -32% |
| Q2 2025 | $9B | -19% |
| Q1 2025 | $11.1B | -14% |
| Q4 2024 | $13.6B | +16% |
META usually generates cash, though not every quarter: the latest was −$1.2B, but it generated $28.6B over the past year.
ATEX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -31.8K shares |
| 1 year | +4.8% | +890K shares |
| 3 years | +2.5% | +486K shares |
| 5 years | +9.6% | +1.7M shares |
| Available history | +15% | +2.5M shares |
ATEX has 20M diluted shares, up 4.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $990,000 |
| Q2 2025 | — |
| Q1 2025 | $2M |
| Q4 2024 | $4.4M |
| Q3 2024 | — |
| Q2 2024 | $2M |
META Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +7M shares |
| 1 year | 0% | +1M shares |
| 3 years | -2.6% | -68M shares |
| 5 years | -10% | -286M shares |
| Available history | -11% | -303M shares |
META has the edge over ATEX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $3.3B |
| Q2 2025 | $10.2B |
| Q1 2025 | $12.8B |
| Q4 2024 | — |
META hasn't bought back shares in the past year.
ATEX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -20.6x | Net Cash |
| Q2 2026 | -1.6x | Net Cash |
| Q1 2026 | -1.0x | Net Cash |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.4x | Net Cash |
| Q2 2025 | -1.6x | Net Cash |
| Q4 2023 | -3.6x | Net Cash |
| Q3 2023 | -6.2x | Net Cash |
ATEX has the edge over META on leverage, with a lower net debt burden relative to earnings.
META Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.2x | Net Cash |
META's net debt is less than a year of its operating earnings (EBITDA).
ATEX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.2 | Neutral |
| Stochastic | 42.7 | Neutral |
ATEX's weekly RSI is 53 (neutral) and its Stochastic is 43 (neutral).
META Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.2 | Neutral |
| Stochastic | 33.7 | Neutral |
META's weekly RSI is 48 (neutral) and its Stochastic is 34 (neutral).
ATEX PE vs Communication Services Sector
| Metric | ATEX | Sector median | Relative |
|---|---|---|---|
| PE | 218x | 16x | 1,220% above |
| PE % | 100 | 26 | 74 pts above |
ATEX is trading at 218x earnings, a 1220% premium to the Communication Services sector's median of 16x.
META PE vs Communication Services Sector
| Metric | META | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 16x | 29% above |
| PE % | 18 | 26 | 8 pts below |
META has the edge over ATEX on valuation relative to its sector.
ATEX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $81.7 | 1.2% above |
| 20 week MA | $88.4 | 6.5% below |
| 50 week MA | $60.6 | 36% above |
| 100 week MA | $43.9 | 88% above |
| 200 week MA | $38.7 | 114% above |
ATEX has the edge over META on trend strength, trading above more of its moving averages.
META Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $674.9 | 7.6% below |
| 20 week MA | $634.5 | 1.7% below |
| 50 week MA | $630.8 | 1.1% below |
| 100 week MA | $647.8 | 3.7% below |
| 200 week MA | $517.5 | 21% above |
META has fallen below most of its moving averages, though it's still 21% above its 200-week average.
ATEX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $42.2 | $39.6 | -6.1% |
| 2021 | $39.6 | $60.1 | +52% |
| 2022 | $60.1 | $30.9 | -49% |
| 2023 | $30.9 | $33.3 | +7.9% |
| 2024 | $33.3 | $30.7 | -7.7% |
| 2025 | $30.7 | $22.0 | -28% |
| 2026 YTD | $22.0 | $82.7 | +276% |
ATEX has the edge over META on returns for 2026, with the stronger performance.
META Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $208.1 | $267.4 | +28% |
| 2021 | $267.4 | $335.2 | +25% |
| 2022 | $335.2 | $118.0 | -65% |
| 2023 | $118.0 | $354.0 | +200% |
| 2024 | $354.0 | $599.8 | +69% |
| 2025 | $599.8 | $663.3 | +11% |
| 2026 YTD | $663.3 | $623.6 | -6% |
META's yearly returns have swung widely, from +200% in 2023 to −65% in 2022. It's down 6% so far in 2026.